What Happened?
Shares of healthcare data analytics company Health Catalyst (NASDAQ: HCAT) jumped 9.4% in the morning session after the company reported first-quarter 2026 results that surpassed analyst revenue and earnings expectations.
Health Catalyst announced revenue of $70.76 million which, despite being a 10.9% decrease from the same period in the previous year, topped analyst forecasts of $69.19 million. The company also reported an adjusted earnings per share of $0.02, beating the consensus estimate of $0.01.
Looking ahead, Health Catalyst provided guidance for the second quarter, expecting total revenue between $68 million and $70 million. For the full year 2026, the company anticipates revenue in the range of $260 million to $265 million. The positive investor reaction suggests the market was focused on the company exceeding current expectations rather than the year-over-year sales decline.
Is now the time to buy Health Catalyst? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Health Catalyst’s shares are extremely volatile and have had 53 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The previous big move we wrote about was 11 days ago when the stock gained 10.8% on the news that strong earnings and upbeat forecasts from several peers boosted the broader software sector.
The gains appeared driven by positive sentiment across the software-as-a-service (SaaS) space. For instance, enterprise software maker Atlassian saw its shares surge after lifting its annual forecast, which in turn lifted peers like Salesforce and ServiceNow.
Similarly, Twilio's stock jumped after it reported first-quarter revenue that beat estimates and raised its own forecast, with its CEO highlighting artificial intelligence as a catalyst. This positive news from peers helped create a favorable environment for software stocks, which some strategists noted had been underperforming the broader market and were potentially positioned for a comeback.
Health Catalyst is down 33.8% since the beginning of the year, and at $1.51 per share, it is trading 66.6% below its 52-week high of $4.52 from May 2025. Investors who bought $1,000 worth of Health Catalyst’s shares 5 years ago would now be looking at only $31.35.
ONE MORE THING: 3 Hidden Platforms Growing 3X Faster than Amazon, Google, and PayPal. Amazon, Google, and Meta all followed the same playbook: Dominate an ignored market. Build an unbeatable moat. Scale until you’re unstoppable.
These three platforms are running that exact playbook right now. The early investors in Amazon made fortunes. The early investors in these could do the same. Get All 3 Stocks Here for FREE.
